Arch Therapeutics Management
Management criteria checks 3/4
Arch Therapeutics' CEO is Terrence Norchi, appointed in Jan 2006, has a tenure of 18.08 years. total yearly compensation is $450.50K, comprised of 100% salary and 0% bonuses, including company stock and options. directly owns 1.58% of the company’s shares, worth $234.82K. The average tenure of the management team and the board of directors is 2.8 years and 1.1 years respectively.
Key information
Terrence Norchi
Chief executive officer
US$450.5k
Total compensation
| CEO salary percentage | 100.0% |
| CEO tenure | 18.1yrs |
| CEO ownership | 1.6% |
| Management average tenure | 2.8yrs |
| Board average tenure | 1.1yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2023 | n/a | n/a | -US$6m |
| Mar 31 2023 | n/a | n/a | -US$6m |
| Dec 31 2022 | n/a | n/a | -US$6m |
| Sep 30 2022 | US$451k | US$451k | -US$5m |
| Jun 30 2022 | n/a | n/a | -US$5m |
| Mar 31 2022 | n/a | n/a | -US$6m |
| Dec 31 2021 | n/a | n/a | -US$7m |
| Sep 30 2021 | US$635k | US$451k | -US$6m |
| Jun 30 2021 | n/a | n/a | -US$6m |
| Mar 31 2021 | n/a | n/a | -US$5m |
| Dec 31 2020 | n/a | n/a | -US$4m |
| Sep 30 2020 | US$698k | US$438k | -US$5m |
| Jun 30 2020 | n/a | n/a | -US$4m |
| Mar 31 2020 | n/a | n/a | -US$5m |
| Dec 31 2019 | n/a | n/a | -US$4m |
| Sep 30 2019 | US$429k | US$429k | -US$5m |
| Jun 30 2019 | n/a | n/a | -US$5m |
| Mar 31 2019 | n/a | n/a | -US$6m |
| Dec 31 2018 | n/a | n/a | -US$8m |
| Sep 30 2018 | US$829k | US$425k | -US$5m |
| Jun 30 2018 | n/a | n/a | -US$6m |
| Mar 31 2018 | n/a | n/a | -US$6m |
| Dec 31 2017 | n/a | n/a | -US$6m |
| Sep 30 2017 | US$1m | US$350k | -US$8m |
Compensation vs Market: Terrence's total compensation ($USD450.50K) is about average for companies of similar size in the UK market ($USD347.22K).
Compensation vs Earnings: Terrence's compensation has been consistent with company performance over the past year.
CEO
Terrence Norchi (58 yo)
18.1yrs
Tenure
US$450,500
Compensation
Dr. Terrence W. Norchi, M.D., serves as Chairman of the Board at Arch Therapeutics, Inc. since July 19, 2018. He is the Co-Founder of Arch Therapeutics, Inc. and has been its Chief Executive Officer and Pr...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 18.1yrs | US$450.50k | 1.58% $ 234.8k | |
| CFO & Treasurer | 2.8yrs | US$325.00k | 0.23% $ 33.9k | |
| Co-Founder & Scientific Advisor | no data | no data | no data | |
| Vice President of Sales | less than a year | no data | no data |
2.8yrs
Average Tenure
Experienced Management: 0HHJ's management team is considered experienced (2.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 10.8yrs | US$450.50k | 1.58% $ 234.8k | |
| Independent Director | 2.2yrs | US$18.35k | 0% $ 0 | |
| Independent Director | 5.6yrs | US$25.00k | 0% $ 0 | |
| Member of Medical Advisory Board | 1.1yrs | no data | no data | |
| Member of Medical Advisory Board | 1.1yrs | no data | no data | |
| Independent Director | 2.4yrs | no data | 0% $ 0 | |
| Member of Medical Advisory Board | 1.1yrs | no data | no data | |
| Member of Medical Advisory Board | 1.1yrs | no data | no data | |
| Member of Medical Advisory Board | 1.1yrs | no data | no data | |
| Member of Medical Advisory Board | no data | no data | no data |
1.1yrs
Average Tenure
58yo
Average Age
Experienced Board: 0HHJ's board of directors are not considered experienced ( 1.1 years average tenure), which suggests a new board.